Last reviewed · How we verify
NCT06900530
Evaluating Sleep Quality With Emerging Technologies
trial in Snoring in 52 participants. Completed in 15 December 2025.
15 December 2025
Quick facts
| Lead sponsor | Case Western Reserve University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 52 |
| Start date | 10 February 2024 |
| Primary completion | 15 December 2025 |
| Estimated completion | 15 December 2025 |
| Sites | 1 location across United States |
Conditions studied
- Snoring — all drugs for Snoring →
- Sleep Disturbances — all drugs for Sleep Disturbances →
- Hypoxia — all drugs for Hypoxia →
- Obstructive Sleep Apnea (OSA) — all drugs for Obstructive Sleep Apnea (OSA) →
Sponsor
Case Western Reserve University
Who can join
Adults 20 to 75, any sex, with Snoring or Sleep Disturbances. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To investigate the sleep quality of the adult orthodontic patient population at the Case Western Reserve University School of Dental Medicine using the NOSE Questionnaire, STOP-BANG Questionnaire, SleepCycle app, and Belun Ring. The sample will consist of adult orthodontic patients who came seeking care at the Case Western Reserve University School of Dental Medicine's Orthodontic Department. Inclusion criteria include adult patients in active treatment in the Case Western Reserve University School of Dental Medicine's Orthodontics Department, age 20 or higher, willingness to give informed consent and participate in the study, possession of a smartphone, and ability to return the Belun Ring and complete the follow-up questionnaire. Exclusion criteria include age less than 20, current or history of taking blood pressure medication, pregnancy, hypovolemia, allergy to thermoplastic elastomers or polycarbonates, anemia, use of mandibular repositioning devices, or active palatal expansion. There were no existing publications similar to our study found in the current literature. So, the required sample size was estimated by the G Power formula for prevalence studies. The global prevalence of AHI 15 was used to estimate the required sample size for this study. The required sample size for 80% power and .05 precision came to 26 subjects.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06900530
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Snoring
Currently open trials in the same condition.
- NCT07103941 — IOA Preventing Occlusal Changes With MAD Use · NA · recruiting
- NCT06594627 — Smart Pillows for Enhancing Sleep Quality · NA · recruiting
- NCT06905951 — The Impact of Technology in Obstructive Sleep Apnea Myofunctional Therapy · NA · active not recruiting
- NCT05719779 — Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer. · NA · recruiting
- NCT03646214 — Improving Sleep Quality During Pregnancy Using an Oral Appliance · NA · recruiting
Other Case Western Reserve University trials
Trials by the same sponsor.
- NCT07216950 — Knowledge and Interpersonal Skills to Develop Enhanced Relationships (KINDER) · Phase 2 · not yet recruiting
- NCT07006935 — REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health) · NA · not yet recruiting
- NCT07214233 — Youth Empowerment and Safety Intervention · NA · recruiting
- NCT07225582 — Development of Optimal Sensory Feedback Strategies to Maximize Function After Tetraplegia · NA · recruiting
- NCT07217249 — Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06900530 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Case Western Reserve University
- Last refreshed: 20 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06900530.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing